scholarly article | Q13442814 |
P2093 | author name string | Cindy Hiegel | |
Lynda Uphouse | |||
Jhimly Sarkar | |||
Jutatip Guptarak | |||
P2860 | cites work | Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes | Q24648866 |
SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake | Q24657383 | ||
Fluoxetine: a review on evidence based medicine | Q24799297 | ||
The neurosteroids, progesterone and 3alpha,5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats | Q28287227 | ||
Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding | Q28378100 | ||
Burden of phase-specific sexual dysfunction with SSRIs | Q30439310 | ||
Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. | Q30486338 | ||
Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex | Q33973888 | ||
A retrospect on the discovery of WAY-100635 and the prospect for improved 5-HT(1A) receptor PET radioligands | Q34016383 | ||
5-HT(1A) receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats | Q34017480 | ||
Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration | Q34174011 | ||
Neurosteroid modulation of GABAA receptors | Q34275980 | ||
Assessing antidepressant activity in rodents: recent developments and future needs | Q34635853 | ||
Antidepressant-induced sexual dysfunction | Q34874381 | ||
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties | Q35037741 | ||
A review and reevaluation of the role of serotonin in the modulation of lordosis behavior in the female rat | Q35851456 | ||
Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs | Q35974100 | ||
Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study | Q71012065 | ||
Female gonadal hormones, serotonin, and sexual receptivity | Q73019374 | ||
5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo | Q73081074 | ||
The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol | Q73571947 | ||
[Depression and sexual dysfunction: aspects of a multi-faceted relationship] | Q81042351 | ||
A novel approach for predicting antidepressant-induced sexual dysfunction in rats | Q81306017 | ||
3alpha-hydroxy-5alpha-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors | Q36329411 | ||
Subchronic treatment with fluoxetine attenuates effects of acute fluoxetine on female rat sexual behavior | Q36477275 | ||
Strategies for managing antidepressant-induced sexual dysfunction: a review | Q36649071 | ||
Synthesis and function of hypothalamic neuroprogesterone in reproduction. | Q36692137 | ||
Neuroendocrine regulation of feminine sexual behavior: lessons from rodent models and thoughts about humans | Q36901990 | ||
Neuroprogesterone: key to estrogen positive feedback? | Q36938797 | ||
Sexual dysfunction associated with antidepressant therapy | Q36993680 | ||
Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography | Q37243720 | ||
Solicitation behavior in the estrous female rat: a review | Q38749487 | ||
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). | Q40666676 | ||
Fluoxetine tenth anniversary update: the progress continues | Q41653513 | ||
Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex | Q42520623 | ||
Changes in sexual function during acute and six-month fluoxetine therapy: a prospective assessment | Q43609177 | ||
Effects of selective 5-HT1A receptor antagonists on regional serotonin synthesis in the rat brain: an autoradiographic study with alpha-[14C]methyl-L-tryptophan | Q43647927 | ||
Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal rel | Q43661980 | ||
Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine | Q44028352 | ||
Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors | Q44126370 | ||
Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior | Q44438197 | ||
Fluoxetine may influence lordosis of rats through effects on midbrain 3 alpha,5 alpha-THP concentrations | Q44781888 | ||
Estrogen and progesterone dose-dependently reduce disruptive effects of restraint on lordosis behavior | Q44816287 | ||
WAY100635 and female rat lordosis behavior | Q44933413 | ||
GABAA-5-HT1A receptor interaction in the mediobasal hypothalamus | Q45114766 | ||
WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality. | Q46352834 | ||
Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine | Q46716754 | ||
Fluoxetine disrupts food intake and estrous cyclicity in Fischer female rats | Q46901407 | ||
5-HT1A receptors mediate (+)8-OH-DPAT-stimulation of extracellular signal-regulated kinase (MAP kinase) in vivo in rat hypothalamus: time dependence and regional differences. | Q46919563 | ||
WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion | Q47887986 | ||
Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior | Q48158601 | ||
Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors | Q48159353 | ||
Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain | Q48161705 | ||
Effect of progesterone on monoamine turnover in the brain of the estrogen-primed rat. | Q48222567 | ||
5-HT2C receptor involvement in female rat lordosis behavior | Q48228149 | ||
Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. | Q48323833 | ||
Infusions of 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) to the ventral tegmental area, but not the substantia nigra, enhance exploratory, anti-anxiety, social and sexual behaviours and concomitantly increase 3alpha,5alpha-THP concentrations | Q48382066 | ||
Functional integration among 5-hydroxytryptamine receptor families in the control of female rat sexual behavior | Q48389911 | ||
Differences in hypothalamic serotonin between estrous phases and gender: an in vivo microdialysis study | Q48456168 | ||
Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT(2A/2C) receptor agonists | Q48529275 | ||
Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum | Q48589813 | ||
5-HT3 receptors in the ventromedial nucleus of the hypothalamus and female sexual behavior | Q48592136 | ||
Subchronic administration of fluoxetine impairs estrous behavior in intact female rats | Q48710963 | ||
Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. | Q48876980 | ||
5-HT1A receptor antagonists and lordosis behavior | Q49022779 | ||
In vivo evidence for progesterone dependent decreases in serotonin release in the hypothalamus and midbrain central grey: relation to the induction of lordosis | Q49062625 | ||
Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study. | Q50919488 | ||
WAY-100635 has high selectivity for serotonin 5-HT(1A) versus dopamine D(4) receptors. | Q51794751 | ||
The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. | Q53801502 | ||
Estrogen desensitizes 5-HT1A receptors and reduces levels of Gz, Gi1 and Gi3 proteins in the hypothalamus | Q62566842 | ||
P433 | issue | 2 | |
P921 | main subject | abnormal lordosis | Q744305 |
P304 | page(s) | 290-296 | |
P577 | publication date | 2010-03-08 | |
P1433 | published in | Hormones and Behaviour | Q15760887 |
P1476 | title | Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition | |
P478 | volume | 58 |
Q38991824 | Animal Models for the Study of Female Sexual Dysfunction |
Q90697470 | Chronic Fluoxetine Impairs the Effects of 5-HT1A and 5-HT2C Receptors Activation in the PAG and Amygdala on Antinociception Induced by Aversive Situation in Mice |
Q37515934 | Comparison of female Fischer and Sprague-Dawley rats in the response to ketanserin |
Q43548532 | Developmental fluoxetine exposure facilitates sexual behavior in female offspring |
Q36204980 | Factors influencing fluoxetine-induced sexual dysfunction in female rats. |
Q22242315 | Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality. |
Q34672013 | Fluoxetine prevents 8-OH-DPAT-induced hyperphagia in Fischer inbred rats |
Q36840540 | Genetic approaches for understanding the role of serotonin receptors in mood and behavior. |
Q37347736 | Long-term consequences of chronic fluoxetine exposure on the expression of myelination-related genes in the rat hippocampus |
Q48111793 | Paroxetine-induced reduction of sexual incentive motivation in female rats is not modified by 5-HT1B or 5-HT2C antagonists |
Q26861672 | Pharmacology of serotonin and female sexual behavior |
Q35731575 | Sprague-Dawley and Fischer female rats differ in acute effects of fluoxetine on sexual behavior |
Q36777115 | Synthesis of novel analogs of cabergoline: improving cardiovascular safety by removing 5-HT2B receptor agonism |
Search more.